These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 8895728

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K, Yamashita H, Mogi A, Takenoshita S, Miyazono K.
    J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
    [Abstract] [Full Text] [Related]

  • 3. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines.
    Kashiwagi Y, Horie K, Kanno C, Inomata M, Imamura T, Kato M, Yamamoto T, Yamashita H.
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):679-85. PubMed ID: 19737884
    [Abstract] [Full Text] [Related]

  • 4. Roles of the conserved CCAAT and GC boxes of the human and mouse type II transforming growth factor-beta receptor genes.
    Bernadt CT, Rizzino A.
    Mol Reprod Dev; 2003 Aug; 65(4):353-65. PubMed ID: 12840808
    [Abstract] [Full Text] [Related]

  • 5. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
    Paterson IC, Matthews JB, Huntley S, Robinson CM, Fahey M, Parkinson EK, Prime SS.
    J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
    [Abstract] [Full Text] [Related]

  • 6. Human cut-like repressor protein binds TGFbeta type II receptor gene promoter.
    Jackson RJ, Antonia SJ, Wright KL, Moon NS, Nepveu A, Muñoz-Antonia T.
    Arch Biochem Biophys; 1999 Nov 15; 371(2):290-300. PubMed ID: 10545217
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of the murine type II transforming growth factor-beta receptor promoter by the transcription factor Egr-1.
    Wilder PJ, Bernadt CT, Kim JH, Rizzino A.
    Mol Reprod Dev; 2002 Nov 15; 63(3):282-90. PubMed ID: 12237943
    [Abstract] [Full Text] [Related]

  • 8. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
    Park B, Jang JS, Park K.
    Int J Oncol; 2000 Sep 15; 17(3):473-8. PubMed ID: 10938386
    [Abstract] [Full Text] [Related]

  • 9. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
    Muro-Cacho CA, Rosario-Ortiz K, Livingston S, Muñoz-Antonia T.
    Clin Cancer Res; 2001 Jun 15; 7(6):1618-26. PubMed ID: 11410498
    [Abstract] [Full Text] [Related]

  • 10. Functional characterization of transforming growth factor beta type II receptor mutants in human cancer.
    De M, Yan W, de Jonge RR, Garrigue-Antar L, Vellucci VF, Reiss M.
    Cancer Res; 1998 May 01; 58(9):1986-92. PubMed ID: 9581843
    [Abstract] [Full Text] [Related]

  • 11. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer.
    Chen T, Carter D, Garrigue-Antar L, Reiss M.
    Cancer Res; 1998 Nov 01; 58(21):4805-10. PubMed ID: 9809982
    [Abstract] [Full Text] [Related]

  • 12. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
    Jiang W, Tillekeratne MP, Brattain MG, Banerji SS.
    Biochemistry; 1997 Dec 02; 36(48):14786-93. PubMed ID: 9402753
    [Abstract] [Full Text] [Related]

  • 13. Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma.
    Lynch MA, Nakashima R, Song H, DeGroff VL, Wang D, Enomoto T, Weghorst CM.
    Cancer Res; 1998 Oct 01; 58(19):4227-32. PubMed ID: 9766642
    [Abstract] [Full Text] [Related]

  • 14. Changes in TGF-beta receptors of rat hepatocytes during primary culture and liver regeneration: increased expression of TGF-beta receptors associated with increased sensitivity to TGF-beta-mediated growth inhibition.
    Nishikawa Y, Wang M, Carr BI.
    J Cell Physiol; 1998 Sep 01; 176(3):612-23. PubMed ID: 9699514
    [Abstract] [Full Text] [Related]

  • 15. Expression of transforming growth factor beta type II receptors in head and neck squamous cell carcinoma.
    Muro-Cacho CA, Anderson M, Cordero J, Muñoz-Antonia T.
    Clin Cancer Res; 1999 Jun 01; 5(6):1243-8. PubMed ID: 10389906
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.
    Cancer Res; 2002 May 15; 62(10):2778-90. PubMed ID: 12019154
    [Abstract] [Full Text] [Related]

  • 17. Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients.
    Tokunaga H, Lee DH, Kim IY, Wheeler TM, Lerner SP.
    Clin Cancer Res; 1999 Sep 15; 5(9):2520-5. PubMed ID: 10499628
    [Abstract] [Full Text] [Related]

  • 18. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.
    Park SH, Kim YS, Park BK, Hougaard S, Kim SJ.
    Oncogene; 2001 Mar 08; 20(10):1235-45. PubMed ID: 11313868
    [Abstract] [Full Text] [Related]

  • 19. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
    Shimanuki T, Hara T, Furuya T, Imamura T, Miyazono K.
    Oncogene; 2007 May 17; 26(23):3311-20. PubMed ID: 17146441
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
    Evangelou A, Jindal SK, Brown TJ, Letarte M.
    Cancer Res; 2000 Feb 15; 60(4):929-35. PubMed ID: 10706107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.